Ask AI
ProCE Banner Activity

The How: Current Predictors of Response to Immune Checkpoint Inhibitors

Slideset
Download this slideset to review expert guidance on optimal biomarker testing in lung cancer, including molecular testing by NGS and PD-L1 testing to predict response to checkpoint inhibitor–based therapy.

Released: November 05, 2019

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Bristol Myers Squibb

Genentech

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Sanjay Mukhopadhyay, MD

Director, Pulmonary Pathology
Department of Pathology
Cleveland Clinic
Cleveland, Ohio